rheumatology
Medicines

Bisphosphonate benefits extend to cancer and cardiovascular events


Benefits of the bisphosphonates may  extend beyond fracture prevention to include reductions in cardiovascular and cancer events and possibly mortality, according to a New Zealand trial. A more in-depth analysis of a six year trial of zoledronate in older women with osteopenia has found benefits on cardiovascular disease and some cancers consistent with those seen ...

Already a member?

Login to keep reading.


OR
© 2019 the limbic